Persistent Asset Partners’s Viridian Therapeutics VRDN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$392K Sell
28,032
-9,179
-25% -$128K 0.29% 78
2025
Q1
$502K Buy
37,211
+11,974
+47% +$161K 0.42% 58
2024
Q4
$489K Buy
+25,237
New +$489K 0.41% 61